Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Rating of Russian Pharmaceutical Distributors (Q1 – Q3 2017)

Wednesday, November 29, 2017

The official start of labeling of pharmaceutical drugs is surely one of the most prominent events of 2017. It is both beneficial and risky for all market players. The benefits include more product distribution control opportunities for manufacturers. The risks involve the desire of the regulators to implement the system in a very short time, which can cause a wide variety of problems for the pharmaceutical wholesalers.

Theoretically, the system will eliminate shady distributors that resell pharmaceuticals, including stolen ones, or transfer the products intended for marketing campaign to other regions. This is unlikely to cause any disturbance within the market. However, it is quite possible for the system to hit smaller regional companies that will not manage to buy the equipment, modernize the software, and raise the staff qualifications within the required time.

It can also affect pharmaceutical drug importers if the customs services become involved. Problems may arise when introducing the system to certain customs posts. At the moment, pharmaceutical drug and API imports are registered at more than 100 posts, which makes it very difficult to include them in the system synchronically.

Read more about rating of Russian pharmaceutical Distributors(Q1-Q3 2017 performance) here:

See the detailed rating in the newspaper Farmatsevtichesky Vestnik (No. 40, 12/05/2017).

Tab 1. Top 15 pharmaceutical distributors with the largest market share of direct shipments of drugs (including preferential shipments), in monetary terms (Q1 – Q3 2017)